Vertex gets EU okay to treat younger cystic fibrosis patients A new EMA approval has expanded the use of Vertex Pharma’s cystic fibrosis therapy Symkevi to children as young as six if they have ...
Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without regular ...
Abstract: The conventional resource allocation methods, using a central node, are not resilient, owing to the failure of the central unit. An advanced solution is to apply distributed optimization by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback